UK fertile ground for switching
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescriptionto- OTC reclassification. David Ridley explores the country’s increasingly attractive switch environment.
You may also be interested in...
UK MHRA Approves Sale Of Reckitt’s Nuromol Outside Pharmacy
Reckitt's Nuromol is the first combination of paracetamol and ibuprofen approved for sale in the UK outside of pharmacy. The company has also been granted one year of exclusivity for the data used to secure the reclassification.
UK's Maxwellia Looking Into Daily Contraceptive Rx-To-OTC Switch
As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects.
Switching Can Help Normalize Self-Care – PAGB’s Michelle Riddalls
Automatic switch from pharmacy to general sales list status and leveraging the power of real-world data are two ways in which the UK's switch system can be made more efficient, according to the PAGB's new senior director of Regulatory Affairs, Michelle Riddalls.